Cesca Therapeutics to Exhibit at 14th International Cord Blood Symposium
June 08, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 08, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be...
Cesca Therapeutics to Present at the LD Micro Invitational Conference
June 06, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Michael Bruch, the...
Cesca Therapeutics Submits Investigational Device Exemption Supplement for SurgWerks™ CLI Pivotal Trial
June 01, 2016 11:15 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has...
Cesca Therapeutics to Exhibit at the 2016 International Society for Cellular Therapy Annual Meeting
May 24, 2016 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 24, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be...
Cesca Therapeutics to Review Recent Corporate Milestones at the Marcum MicroCap Conference
May 20, 2016 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 20, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company’s...
Cesca Therapeutics Announces Publication of a Case Report on Use of Its Technology for Treatment of Acute Myocardial Infarction
May 19, 2016 06:00 ET
|
Cesca Therapeutics Inc.
Data highlights promising results obtained from the AMIRST pilot study. RANCHO CORDOVA, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based...
Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update
May 12, 2016 16:37 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today reported financial results for the third...
Cesca Reports Data From Six CLI Compassionate Use Patients Treated With SurgWerks™ Procedures at Fortis Escorts Heart Institute in New Delhi
May 11, 2016 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced the results of six late-stage...
Cesca Therapeutics to Report Third Quarter Fiscal 2016 Results on May 12, 2016
May 09, 2016 18:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report...
Cesca Therapeutics To Present A Poster At The 2016 Annual Meeting Of The European Society For Blood And Bone Marrow Transplantation
March 31, 2016 06:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 31, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will...